WASHINGTON, Feb. 3, 2026 /PRNewswire/ -- The Trustworthy Accountability Group (TAG), the leading global initiative dedicated to fighting criminal activity and increasing trust in digital advertising, ...
Alector, Inc. pivots to its Alector Brain Carrier platform, focusing on enhanced blood-brain barrier delivery for neurodegenerative therapeutics. Near-term stock movement hinges on the binary outcome ...
On track to report topline data by mid-Q4 2025 from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN, a severe, rare form of dementia with no approved treatments Ongoing Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results